Previous 10 | Next 10 |
JERSEY, Channel Islands, June 17, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal fourth quarter and full year ended March 31, 2022 will be released before market open on Wednesday, June ...
Partnership brings together novel technology and clinical applications expertise to produce automated, multiplexed solutions for advancing autoimmune diagnostics Expands access to $2 billion autoimmune IVD specialty market with MosaiQ Targeted market introduction in the ...
Diversified global presence key to Company's go-to-market strategy Strengthened geographical expansion with distributor strategy model to better support customers in the region JERSEY, Channel Islands, May 17, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercia...
Virtual event on Monday, May 23 rd at 11:00 AM ET The webinar will provide a detailed discussion on the current landscape and unmet needs within blood grouping and donor disease screening JERSEY, Channel Islands, May 12, 2022 (GLOBE NEWSWIRE) -- Quotient Li...
JERSEY, Channel Islands, April 26, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced the appointment of Thomas Aebischer to Quotient Board of Directors effective as of May 1, 2022. Mr. Aebischer will also serve on the Board's A...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Value has outperformed growth by a substantial margin ove...
JERSEY, Channel Islands, March 21, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced New York Blood Center, Inc. , USA, and Centro de Transfusiones de la Comunidad d...
Quotient (NASDAQ:QTNT) received Conformité Européenne (CE) Mark for its MosaiQ Extended Immunohematology (IH) Microarray. The status allows the company to sell the microarray for use with its MosaiQ instrument across the EU. The company said its MosaiQ platform offers an all-in...
JERSEY, Channel Islands, March 08, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced it has received Conformité Européenne (CE) Mark for its MosaiQ Extended Immu...
JERSEY, Channel Islands, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that the management team will participate in the Cowen 42nd Annual Health Care Conference. As part of the conference, the Company ...
News, Short Squeeze, Breakout and More Instantly...
Quotient Limited Company Name:
QTNT Stock Symbol:
NASDAQ Market:
3 Tips and Tricks For Managing Risk With Penny Stocks Risk management is an essential component of penny stock trading, as these stocks are often volatile and unpredictable. Proper risk management helps to minimize potential losses by setting strict limits on the amount of money that can be l...
3 Techniques for Day Trading Penny Stocks in 2023 Day trading penny stocks is a popular investment strategy due to its potential for high returns. The stock market can be volatile, and when done correctly, day trading penny stocks offers investors the opportunity to capitalize on quick fl...
JERSEY, Channel Islands, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the "Company") today announced that it has given formal notice to the Nasdaq Stock Market LLC ("Nasdaq") of its intention to voluntarily delist its ordinary shares from the Nasdaq Global Market. In order t...